Literature DB >> 3425409

Postoperative controls in surgically treated hormonactive pituitary adenomas by use of magnetic resonance imaging.

R Oeckler1, U Fink.   

Abstract

The search of reliable imaging methods to detect the substrate for persisting hypersecretion in patients operated on for hormonactive pituitary adenoma prompted us to study the possibilities of the newly available Magnetic Resonance Imaging (MRI) technique in this regard. Pre- and postoperative MRI-studies where performed in 5 patients with persisting GH excess following transsphenoidal surgery as well as in 3 patients with micro- and 2 patients with macroprolactinomas. The MRI-findings were correlated with the results of the endocrinological examinations. Two acromegalic patients and three cases with microprolactinomas, who were successfully operated upon as defined by the functional criteria were also included to obtain a baseline for normal postoperative findings. The MRI-study was positive in all of the five patients with persisting GH-overproduction. In prolactinomas, the substrate of hypersecretion could only be detected, when the PRL-value exceeded 2,000 microU/ml. MRI may present an important diagnostic method for evaluating further treatment options in patients with remaining hormonal hypersecretion following transsphenoidal adenomectomy, particularly with regard to a second surgical approach.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3425409     DOI: 10.1007/BF01400510

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  14 in total

1.  INVASIVE PITUITARY ADENOMAS.

Authors:  A N MARTINS; G J HAYES; L G KEMPE
Journal:  J Neurosurg       Date:  1965-03       Impact factor: 5.115

2.  Inhibitory effect of L-Dopa on GH release in acromegalic patients.

Authors:  A Liuzzi; P G Chiodini; L Botalla; G Cremascoli; F Silvestrini
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

3.  Transsphenoidal hypophysectomy: postsurgical CT findings.

Authors:  C A Dolinskas; F A Simeone
Journal:  AJR Am J Roentgenol       Date:  1985-03       Impact factor: 3.959

4.  Computed tomographic study of hormone-secreting microadenomas.

Authors:  S Hemminghytt; R K Kalkhoff; D L Daniels; A L Williams; J P Grogan; V M Haughton
Journal:  Radiology       Date:  1983-01       Impact factor: 11.105

5.  Magnetic resonance imaging of pituitary lesions using 1.0 to 1.5 T field strength.

Authors:  L T Bilaniuk; R A Zimmerman; F W Wehrli; P J Snyder; H I Goldberg; R I Grossman; P A Bottomley; W A Edelstein; G H Glover; J R MacFall
Journal:  Radiology       Date:  1984-11       Impact factor: 11.105

6.  Recurrent pituitary adenomas.

Authors:  F Marguth; R Oeckler
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

7.  Brain stem necrosis after irradiation of pituitary adenoma.

Authors:  A Fukamachi; T Wakao; J Akai
Journal:  Surg Neurol       Date:  1982-11

8.  Recent developments in the treatment of acromegaly.

Authors:  D K Lüdecke
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

9.  Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: results in 230 patients.

Authors:  H J Quabbe
Journal:  Clin Endocrinol (Oxf)       Date:  1982-02       Impact factor: 3.478

10.  Neurosurgical experience with magnetic resonance imaging in sellar lesions.

Authors:  R Oeckler; U Fink; B Mayr
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.